Skip to search formSkip to main contentSkip to account menu

Estramustine phosphate

Known as: Estramustin Phosphate, Estramustinphosphate, Phosphate, Estramustin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BackgroundTo assess the outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade followed by treatment… 
Highly Cited
2001
Highly Cited
2001
PURPOSE To determine the safety and activity of weekly paclitaxel in combination with estramustine and carboplatin (TEC) in… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND To apply our preclinical findings of cytotoxic synergy with the combination of estramustine phosphate (EP) and… 
Review
1999
Review
1999
Purpose: Microtubules are important cytoskeletal components involved in many cellular events. Antimicrotubule agents including… 
Highly Cited
1999
Highly Cited
1999
PURPOSE To compare vinblastine versus the combination of vinblastine plus estramustine as treatment for patients with hormone… 
Highly Cited
1997
Highly Cited
1997
PURPOSE To evaluate the antitumor activity of 96-hour paclitaxel and daily oral estramustine phosphate (EMP) in patients with… 
Highly Cited
1993
Highly Cited
1993
To investigate the mechanism of action of the antineoplastic drug estramustine, we compared its effects on human prostate cancer… 
Highly Cited
1992
Highly Cited
1992
PURPOSE Estramustine phosphate (EMP) and vinblastine are two microtubule inhibitors with distinct molecular targets and at least…